['lizbeth]

The information I posted above is from:

The Cancer and Leukemia Group B (CALGB) is a national clinical research group sponsored by the National Cancer Institute, with the Central Office headquartered at the University of Chicago and Statistical Center located at Duke University. Founded in 1956, the CALGB brings together clinical oncologists and laboratory investigators to develop better treatments for cancer. CALGB has grown exponentially over the years into a national network of 26 university medical centers, more than 200 community hospitals and more than 3,000 oncology specialists who collaborate in clinical research studies. These studies aim to reduce morbidity and mortality from cancer, relate biological characteristics of cancer to clinical outcomes, and develop new strategies for the early detection and prevention of cancer.


This was a large study with over 3000 women. You seem to fit the criteria good risk invasive breast cancer with 0 to 3 positive nodes.

Your breast surgeon has likely seen the results of this study.

You can feel confident that 4 treatments of the taxane will be enough. You will have an entire year of Herceptin.

Please consider a vaccine trial, diet/exercise study or other study to reduce risk during or subsequent to your treatment.

Wishing you the best of health.